'Molecular assassin' targets disease gene

University of New South Wales researchers have announced they are developing a new class of experimental drug that has the potential to treat a diverse range of health problems, from inflammation and cancer through to eye and heart disease. The research is published in the July issue of Nature Biotechnology.

If you want to include this story in your blog, copy and paste this formatted text: